LOTRIMIN
Pronunciation: kloe-TRIM-a-zoel


What it isImidazole CYP51 inhibitor; tinea and cutaneous, vulvovaginal or oropharyngeal candidiasis.
Why this oneSpans OTC skin and vaginal products plus prescription oral troches, an unusually broad set of local formulations.
What limits itTroches can raise tacrolimus exposure despite minimal absorption; local burning occurs, and no form treats invasive disease.
Animated chart of estimated U.S. prescriptions per year, Antifungals (1947–2026). Clotrimazole enters in 1975 (estimated).
Principal riskLittle; topical
Legacy pregnancy categoryC
Defining liabilityLocal irritation or hypersensitivity; systemic toxicity is minimal with correct local use.
Read the full label on DailyMed ↗
NO BOXED WARNINGS
| FDA dosing | Population | Start | Target | Max |
|---|---|---|---|---|
| Athlete's foot / ringworm | Adult (supervise children) | Apply thin layer BID (AM & PM) | Apply thin layer BID x4 weeks | |
| Jock itch | Adult (supervise children) | Apply thin layer BID (AM & PM) | Apply thin layer BID x2 weeks |
Renal Undefined
Hepatic Undefined
Athlete's foot/ringworm: 4-week course; jock itch: 2-week course
Available strengths
Pregnancy Undefined
Lactation Undefined
| Strength | #/mo | generic $/unit | CostPlus | |
|---|---|---|---|---|
| 1 % | sol | per unit | not offered | |
| 1 % | cream | per unit | not offered | |
| 2 % | cream | per unit | not offered |
Generic entry1993
Open Clotrimazole in the interactive console ↗